首页 | 本学科首页   官方微博 | 高级检索  
     

替尼泊甙治疗恶性脑胶质瘤的远期结果
引用本文:张天锡,赵卫国,孙青芳,田恒力. 替尼泊甙治疗恶性脑胶质瘤的远期结果[J]. 中国神经精神疾病杂志, 1995, 0(1)
作者姓名:张天锡  赵卫国  孙青芳  田恒力
作者单位:上海第二医科大学瑞金医院神经外科
摘    要:报道替尼泊甙-CCNU治疗恶性脑胶质瘤96例随诊1~10年的远期结果.男性66例、女性30例.年龄5~74岁,平均39.7岁。治疗周期总数448个,平均5个/例.远期结果计:CR18例、PR21例,RR率40.7%;SD19例、PD37例、ED1例.存活率为:1年85%、3年26%、5年14.6%、10年1%。目前仍存活之14例中已逾5年者5例.平均有效时限为CR组212周、PR组121周、SD组46周、PD组12周。平均存活时限为CR组241周、PR组133周、SD组57周、PD组18周。

关 键 词:替尼泊甙,环己亚硝脲,化疗,恶性脑胶质瘤

Long term results of Teniposide-CCNU chemotherapy in the treatment of malignant brain gliomas.
Zhang Tianxi,et al.. Long term results of Teniposide-CCNU chemotherapy in the treatment of malignant brain gliomas.[J]. Chinese Journal of Nervous and Mental Diseases, 1995, 0(1)
Authors:Zhang Tianxi  et al.
Abstract:One to ten years' follow-up of 96 cases of malignant gliomas treated with Teniposide CCNU are reported. 66 were males and 30were females, with an average age of 39.7year --old (range 5 -- 74 years old ). A total of 448 chemotherapy circles were used, averaging 5/case. The therapeutic results were CR in 18cases, PR in 21 cases (with an overall response rate of 40.7%), SD in 19 cases, PD in 37 cases, ED in I case. The I -year,survival rate was 85%, 3 --year 26%,5-year 14.6%,10- year 1 %. The average duration of remission for CR group was 212 weeks, PR group 121weeks, SD group 66 weeks and PD group 22weeks. The average survival for CR group was 241 weeks, PR group 133 weeks, SD group 87 weeks and PD group 28 weeks.
Keywords:Teniposide CCNU tChemo therapy Malignant brain glioma  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号